Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 8—August 2002
Research

Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan

Po-Ren Hsueh*, Lee-Jene Teng*, Cheng-Yi Chen*, Wen-Hwei Chen*, Shen-Wu Ho*Comments to Author , and Kwen-Tay Luh*
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan;

Main Article

Table 1

In vitro susceptibilities for 203 clinical isolates of pandrug-resistant Acinetobacter baumannii (PDRAB) determined by disk diffusion

MIC (µg/mL) % of isolates
Antibiotic
Range
MIC50
MIC90
S
I
R
Ampicillin 64–>128 >128 >128 - - -
SAM 4–>128 64 128 3 3 94
Ceftazidime 16–>128 >128 >128 0 1 99
Cefepime 16–>128 >128 >128 0 1 99
Flomoxef 64–>128 >128 >128 - - -
TZP 32–>128 >128 >128 0 4 96
Aztreonam 8–>128 64 128 1 1 98
Imipenem 8–64 8 32 0 62 38
Meropenem 8–128 16 128 0 8 92
Amikacin 32–>128 >128 >128 0 6 94
Ciprofloxacin 2–>128 64 128 0 6 94
Trovafloxacin 4–32 8 16 - - -
Moxifloxacin 2–16 8 16 - - -

TZP, piperacillin-tazobactam; SAM, ampicillin-sulbactam.

Main Article

Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external